AI assistant
AbbVie Inc. — Director's Dealing 2018
Mar 2, 2018
29755_dirs_2018-03-02_498da87d-497f-4a37-a01e-ceb424a748dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2018-02-28
Reporting Person: ALBAN CARLOS (EVP, Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-28 | Common stock, $0.01 par value | F | 25976 | $118.26 | Disposed | 133026 | Direct |
| 2018-02-28 | Common stock, $0.01 par value | S | 2579 | $117.8474 | Disposed | 130447 | Direct |
| 2018-03-01 | Common stock, $0.01 par value | M | 48100 | $29.2265 | Acquired | 178547 | Direct |
| 2018-03-01 | Common stock, $0.01 par value | S | 19169 | $113.7511 | Disposed | 159378 | Direct |
| 2018-03-01 | Common stock, $0.01 par value | S | 46997 | $114.6342 | Disposed | 112381 | Direct |
| 2018-03-01 | Common stock, $0.01 par value | S | 14829 | $114.4278 | Disposed | 97552 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-01 | Option (right to buy) | $29.2265 | M | 48100 | Disposed | 2022-02-16 | Common Stock (48100) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 40442 | Indirect |
Footnotes
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.847 to $117.861, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.53 to $113.97, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.00 to $114.965, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.00 to $115.965, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: Held in the Maria Cristina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
F6: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.